Contura Orthopedics Expands to Canada, Bringing Arthrosamid® to North America

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Arthrosamid-Contura

More Like This

PR Newswire associated0

Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™

Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics

PR Newswire associated0

ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe

PR Newswire associated0

AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain

Nanochon Announces Health Canada Approval for First in Human Investigation

PR Newswire associated0

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

No serious adverse events to date in ongoing phase 1/2a clinical study of SYN321